Rubia, Nicanor C.

HRN: 12-50-18  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/01/2024
CEFTRIAXONE 1G (VIAL)
08/01/2024
08/08/2024
IV
2g
Q24
CAP MR
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes